Seelos Therapeutics (SEEL)
NASDAQ:SEEL
Holding SEEL?
Track your performance easily

Seelos Therapeutics (SEEL) Financial Statements

1,160 Followers

Seelos Therapeutics Financial Overview

Seelos Therapeutics's market cap is currently ―. The company's EPS TTM is $11.04; its P/E ratio is 0.02; Seelos Therapeutics is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 376.00K$ 579.00K$ 406.00K$ 336.00K$ 875.00K
Gross Profit$ 376.00K$ 579.00K$ 406.00K$ 336.00K$ 875.00K
EBIT$ 1.73M$ -2.44M$ 10.54M$ -29.49M$ -9.19M
EBITDA$ 1.75M$ -2.42M$ 10.55M-$ -9.18M
Net Income Common Stockholders$ 1.71M$ -2.66M$ 10.50M$ -29.50M$ -13.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 300.00K$ 500.00K$ 2.58M$ 5.80M$ 14.10M
Total Assets$ 2.38M$ 3.61M$ 6.22M$ 11.89M$ 23.68M
Total Debt$ 10.16M$ 13.14M$ 16.91M$ 15.34M$ 16.78M
Net Debt$ 9.86M$ 12.64M$ 14.32M$ 9.54M$ 2.68M
Total Liabilities$ 30.51M$ 36.72M$ 36.63M$ 59.07M$ 44.30M
Stockholders Equity$ -28.13M$ -33.10M$ -30.41M$ -47.18M$ -20.68M
Cash Flow-
Free Cash Flow$ -972.00K$ -4.64M$ -5.75M-$ -10.35M
Operating Cash Flow$ -972.00K$ -4.64M$ -5.75M$ -5.90M$ -10.35M
Investing Cash Flow-----
Financing Cash Flow$ 742.00K$ 2.17M$ 2.49M$ -2.31M$ 8.87M
Currency in USD

Seelos Therapeutics Earnings and Revenue History

Seelos Therapeutics Debt to Assets

Seelos Therapeutics Cash Flow

Seelos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis